Evidence map›Paper›PMID 41416003›Full record

ArticleSurgical oncology insight2025

Facilitators to oncological care in foregut cancer: The patient perspective.

Jaspinder S Sanghera, Michelle M Holland, Ioannis Liapis, Rida Ahmad, Katie West, Manish Tripathi, Larry Hearld, Daniel I Chu, Krista Mehari, Martin J Heslin and 2 more

Abstract read
In one paragraph

Article in Surgical oncology insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jaspinder S SangheraUniversity of Alabama at Birmingham, Department of Surgery, USA.
Michelle M HollandUniversity of Alabama at Birmingham, Department of Surgery, USA.
Ioannis LiapisUniversity of Alabama at Birmingham, Department of Surgery, USA.
Rida AhmadUniversity of South Alabama, Department of Surgery, USA.
Katie WestRice University, Department of Biosciences, USA.
Manish TripathiUniversity of Alabama at Birmingham, Institute of Cancer Outcomes and Survivorship, USA.
Larry HearldUniversity of Alabama at Birmingham, Department of Health Services Administration, USA.
Daniel I ChuUniversity of Alabama at Birmingham, Department of Surgery, USA.
Krista MehariVanderbilt University, Department of Psychology, USA.
Martin J HeslinUniversity of Alabama at Birmingham, Department of Surgery, USA.
Smita BhatiaUniversity of Alabama at Birmingham, Institute of Cancer Outcomes and Survivorship, USA.
Annabelle L FonsecaUniversity of Alabama at Birmingham, Department of Surgery, USA.

Funding

Using Modifiable Factors to Predict Risk of non-Guideline Concordant Treatment in Foregut Cancers: A Novel Implementation Science-based approachK23MD018383 · NIMHD · UNIVERSITY OF SOUTH ALABAMA · PI Annabelle L Fonseca · 2023 to 2026
$647k
NIMHD NIH HHS K23 MD018383
6 · The paper itself

Abstract

Background: Foregut cancers are best treated by specialized, multidisciplinary care, often delivered, at least in part, at tertiary centers. Patient perspectives on the factors that enhance access to and adherence to cancer treatment remain underexplored. This qualitative study explores patient-reported facilitators of care at a safety-net hospital in the Southeastern United States (US). Methods: Patients with foregut cancer receiving care at a safety-net tertiary care institution in the Southeastern US were recruited. Interviews were recorded, transcribed, and analyzed using NVivo 14 Software. Grounded theory methodology was used to identify themes and subthemes. A comprehensive codebook was established, with a high interrater reliability rate of > 90 % for all themes. Results: Of the 30 patients interviewed, the majority were male (n = 23, 77 %) and Black (n = 18, 60 %), with an average age of 63 (IQR: 55-67). Facilitator themes were identified across four categories: (1) Individual/Interpersonal; (2) Provider/Care Team; (3) Healthcare Systems, and (4) Broader Policy. The most prevalent facilitators identified included faith and spirituality (87 %), support from immediate family (83 %), trust in the care team (90 %), and effective communication (97 %). Conclusion: Understanding patient perspectives is essential for delivering high-quality care in foregut cancer. These facilitators should be actively promoted during the development of future interventions. An appreciation of patient beliefs, communication training for care providers, hiring necessary ancillary staff, use of written handouts, expanding financial aid services, and wider healthcare reform are all avenues to explore in the ongoing effort to improve comprehensive oncological care for patients.

Indexed as

Cancer careDisparitiesFacilitatorsForegut cancerPatient reportedPerspectives

Identifiers

PMID41416003
PMCPMC12710860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.